We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NIH Suspends Drug Production at 2 Facilities Over Sterility Issues
NIH Suspends Drug Production at 2 Facilities Over Sterility Issues
The National Institutes of Health has suspended production at two of its facilities following an investigation last year that found a National Cancer Institute laboratory conducting cell therapy production and a National Institute of Mental Health facility producing positron emission tomography materials, were not GMP-compliant.